Madison (US) facility

Labcorp has expanded its preclinical lab to accelerate cell and gene therapy development from discovery to IND/CTA submission. Purpose-built to support the unique complexities of CGT, the facility features 29 flexible animal rooms, ultra-clean necropsy space for high-quality molecular analysis, and integrated stereotaxic and MRI surgical suites for safe delivery in immunocompromised models. With tripled CGT capacity, expanded immunology labs, and expertise in complex administration routes—including direct CNS delivery—Labcorp enables faster study starts and streamlined execution. Backed by 25+ years of experience and deep therapeutic specialization in ocular, CNS, musculoskeletal, cardiometabolic, autoimmune, and blood disorders, our team of PhD-level scientists and skilled technicians helps de-risk your preclinical investment and drive innovation forward.